What does Atle Fund Management AB hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Atle Fund Management AB filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

ELI LILLY & CO

$27M40K8.7%

MERCK & CO. INC

$23M34K7.4%

THERMO FISHER SCIENTIFIC CORP

$14M23K4.7%

BEONE MEDICINES LTD-ADR

$12M42K3.9%

JOHNSON & JOHNSON

$12M92K3.9%

BRIDGEBIO PHARMA INC

$12M111K3.8%

VERTEX PHARMACEUTICALS INC

$11M23K3.6%

ABBVIE INC

$10M108K3.4%

STRYKER CORPORATION

$10M27K3.1%

INTUITIVE SURGICAL INC

$9M71K3.0%

Filing history loading…